PTC Therapeutics
PTCT
PTCT
201 hedge funds and large institutions have $2.94B invested in PTC Therapeutics in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 80 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 39
25% less capital invested
Capital invested by funds: $3.94B → $2.94B (-$997M)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
201
Holding in Top 10
5
Calls
$15.3M
Puts
$5.63M
Top Buyers
| 1 | +$41.8M | |
| 2 | +$23.5M | |
| 3 | +$18.9M | |
| 4 |
BlackRock
New York
|
+$18.2M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$12.5M |
Top Sellers
| 1 | -$81.2M | |
| 2 | -$37.4M | |
| 3 | -$25.5M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$14.6M |